PREDATOR

Welcome to the Brand page for “PREDATOR”, which is offered here for Research and development of pharmaceuticals for the diagnosis and/or treatment of cancer and immunological diseases and disorders; scientific and medical research relating to the diagnosis and/or treatment of cancer and immunological diseases and disorders; consulting services in the field of pharmaceutical research and development;.

Its status is currently believed to be active. Its class is unavailable. “PREDATOR” is believed to be currently owned by “Werewolf Therapeutics, Inc.”